Ariana Sattler, Ph.D., is first author on a new study that found that certain nerves may support pancreatic cancer growth. (OHSU/Christine Torres Hicks)

Ariana Sattler, Ph.D., right, and Ece Eksi, Ph.D., are co-authors on a new study that found that certain nerves may support pancreatic cancer growth. (OHSU/Christine Torres Hicks)

Alan Lynn, a former OHSU patient treated for leukemia in 2021 and patient advocate who contributed to the design of Vista Pavilion, talks with Brian Druker, M.D., chief executive officer of the OHSU Knight Cancer Institute, at the ribbon cutting for the new building, which will be dedicated to delivering cancer care. (OHSU/Christine Torres Hicks)

Leaders and patients mark a major expansion at Oregon Health & Science University with a ribbon-cutting for the new Vista Pavilion, a cancer‑focused building that opens to patients Tuesday, April 7. (OHSU/Christine Torres Hicks)

Brian Druker, M.D., speaks. Leaders and patients mark a major expansion at Oregon Health & Science University with a ribbon-cutting for the new Vista Pavilion, a cancer‑focused building that opens to patients Tuesday, April 7. (OHSU/Christine Torres Hicks)

OHSU President Shereef Elnahal, M.D., M.B.A., and Brian Druker, M.D., chief executive officer of the OHSU Knight Cancer Institute, cut the ribbon in celebration of the opening of the new Vista Pavilion building at OHSU. (OHSU/Christine Torres Hicks)

A team at Oregon Health & Science University last month became the first center in the Pacific Northwest to perform a new procedure involving the targeted delivery of high-dose chemotherapy to the liver. (OHSU)

The Knight Cancer Precision Biofabrication Hub, led by Luiz Bertassoni, D.D.S., Ph.D., and includes researchers such as Alexander Davies, D.V.M., Ph.D., has been awarded more than $9 million from the NIH for cutting-edge biofabrication research. (OHSU/Christine Torres Hicks)